Point-of-Care (POC) Analyzers - Medical Devices Pipeline Assessment, 2019

Published by Global Data on 1st December 2019 | Ref: 1464195 | This Product Is In Stock

$4000 | Single User
$8000 | Site License
$12000 | Enterprise License
$4000 | Single User
$8000 | Site License
$12000 | Enterprise License

Introduction

Point-of-Care (POC) Analyzers - Medical Devices Pipeline Assessment, 2019

Summary

GlobalData's Medical Devices sector report, “Point-of-Care (POC) Analyzers - Medical Devices Pipeline Assessment, 2019" provides an overview of Point-of-Care (POC) Analyzers currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Point-of-Care (POC) Analyzers pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Point-of-Care (POC) Analyzers under development

- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

- The report reviews the major players involved in the development of Point-of-Care (POC) Analyzers and list all their pipeline projects

- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

- The report provides key clinical trial data of ongoing trials specific to pipeline products

- Recent developments in the segment / industry

Reasons to buy

The report enables you to -

- Formulate significant competitor information, analysis, and insights to improve R&D strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Identify and understand important and diverse types of Point-of-Care (POC) Analyzers under development

- Develop market-entry and market expansion strategies

- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

- In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

Table of Contents

1.1 List of Tables 7

1.2 List of Figures 11

2 Introduction 12

2.1 Point-of-Care (POC) Analyzers Overview 12

3 Products under Development 13

3.1 Point-of-Care (POC) Analyzers - Pipeline Products by Stage of Development 13

3.2 Point-of-Care (POC) Analyzers - Pipeline Products by Territory 14

3.3 Point-of-Care (POC) Analyzers - Pipeline Products by Regulatory Path 15

3.4 Point-of-Care (POC) Analyzers - Pipeline Products by Estimated Approval Date 16

3.5 Point-of-Care (POC) Analyzers - Ongoing Clinical Trials 17

4 Point-of-Care (POC) Analyzers - Pipeline Products under Development by Companies 18

4.1 Point-of-Care (POC) Analyzers Companies - Pipeline Products by Stage of Development 18

4.2 Point-of-Care (POC) Analyzers - Pipeline Products by Stage of Development 21

5 Point-of-Care (POC) Analyzers Companies and Product Overview 24

5.1 Access Bio Inc Company Overview 24

5.2 Acrongenomics Inc (Inactive) Company Overview 25

5.3 AgPlus Diagnostics LTD Company Overview 26

5.4 Akers Biosciences Inc Company Overview 27

5.5 Akonni Biosystems Inc Company Overview 29

5.6 Alere Inc Company Overview 30

5.7 Analytical Diagnostic Solutions Inc Company Overview 31

5.8 ApoCell Inc Company Overview 33

5.9 Aptatek BioSciences Inc Company Overview 34

5.10 Atonomics A/S Company Overview 35

5.11 BBB Technologies Inc Company Overview 36

5.12 Binghampton University Company Overview 37

5.13 Bio-AMD Inc Company Overview 38

5.14 BioMedomics Inc Company Overview 39

5.15 Biopico Systems Inc Company Overview 40

5.16 Biosensia Ltd Company Overview 41

5.17 Boston University Company Overview 42

5.18 BreviTest Technologies LLC Company Overview 43

5.19 Brigham and Women's Hospital Company Overview 44

5.20 Calmark Sweden AB Company Overview 45

5.21 Canon USA Inc Company Overview 47

5.22 CardioGenics Inc Company Overview 48

5.23 Center for Innovation in Point-of-Care Technologies for HIV/AIDS Company Overview 49

5.24 Cepheid Company Overview 51

5.25 ChipCare Corp Company Overview 54

5.26 City, University of London Company Overview 55

5.27 Co-Diagnostics Inc Company Overview 56

5.28 Cornell University Company Overview 57

5.29 Cutting Edge Medical Devices Limited Company Overview 58

5.30 Diagnostics For All Inc Company Overview 59

5.31 Duke University Company Overview 60

5.32 EKF Diagnostics Holdings Plc Company Overview 61

5.33 Endeavor Sciences Inc Company Overview 62

5.34 ExcitePCR Corp Company Overview 63

5.35 Exosome Diagnostics Inc Company Overview 64

5.36 Fawkes Biotechnology LLC Company Overview 65

5.37 First Light Diagnostics Inc Company Overview 66

5.38 Florida International University Company Overview 67

5.39 Future Diagnostics Solutions BV Company Overview 68

5.40 Giner Inc Company Overview 69

5.41 GlucoSentient Inc Company Overview 70

5.42 Indian Institute of Science Company Overview 71

5.43 Indian Institute of Technology Chennai Company Overview 72

5.44 Lucendi Inc Company Overview 73

5.45 Masaryk University Company Overview 74

5.46 Maxygen-mobile DNA tests Company Overview 75

5.47 mBio Diagnostics Inc Company Overview 76

5.48 McKesson Corp Company Overview 78

5.49 Meridian Bioscience Inc Company Overview 79

5.50 MML Ltd Company Overview 80

5.51 Molecular Warehouse Ltd Company Overview 81

5.52 Nalia Systems Ltd Company Overview 82

5.53 Newcastle University Company Overview 83

5.54 Nikkiso Co Ltd Company Overview 85

5.55 Ohmx Corp Company Overview 86

5.56 OncoGenesis Company Overview 87

5.57 Ontera Inc Company Overview 88

5.58 Pacific Nanoscience, Inc. Company Overview 89

5.59 POC Medical Systems Inc Company Overview 90

5.60 ProciseDx LLC Company Overview 91

5.61 Quanterix Corp Company Overview 92

5.62 Qvella Corp Company Overview 93

5.63 Radisens Diagnostics Ltd Company Overview 94

5.64 Raman Diagnostics Ltd (Inactive) Company Overview 95

5.65 RMIT University Company Overview 96

5.66 SeLux Diagnostics Inc Company Overview 97

5.67 SenGenix Inc Company Overview 99

5.68 StemTek Therapeutics SL Company Overview 100

5.69 Thermal Gradient Inc Company Overview 101

5.70 Trinity Biotech Plc Company Overview 103

5.71 University of Calgary Company Overview 105

5.72 University of California Berkeley Company Overview 106

5.73 University of Glasgow Company Overview 109

5.74 University of Illinois at Chicago Company Overview 110

5.75 Wellstat Diagnostics LLC Company Overview 111

6 Point-of-Care (POC) Analyzers- Recent Developments 112

6.1 Oct 30, 2019: First Light Diagnostics joins global initiative to combat antibiotic resistance 112

6.2 Oct 30, 2019: McKesson reports fiscal 2020 second-quarter results 112

6.3 Oct 23, 2019: bioMerieux – Third-Quarter 2019 Business Review 114

6.4 Oct 22, 2019: bioMerieux – Third quarter 2019 business review 115

6.5 Oct 18, 2019: Calmark extends the time plan for CE-mark of the biomarkers LDH and Glucose - market launch as according to plan 117

6.6 Oct 18, 2019: McKesson’s Board of Directors appoints Maria Martinez as new independent Director 117

6.7 Oct 16, 2019: BioDirection announces move of corporate headquarters to Southborough, Massachusetts 118

6.8 Oct 08, 2019: Results for Calmark's initial biomarker, bilirubin, are within the expected range - project enters verification and validation phase to obtain CE mark 119

6.9 Oct 02, 2019: Selux Diagnostics beats key contract milestone, receives .4m in additional funding 119

6.10 Sep 25, 2019: Dr. Joanne Spadoro Joins First Light Diagnostics 120

7 Appendix 152

7.1 Methodology 152

7.2 About GlobalData 155

7.3 Contact Us 155

7.4 Disclaimer 155

Additional Details

Publisher

Global Data

Publisher Information

Reference

1464195 | GDME0825EPD

Number of Pages

155

Report Format

PDF

Related Reports

Title
Date Published
Price From
Link

Published by LP Information
06-11-2018

$4,660 USD

Published by LP Information
06-11-2018

$4,660 USD

This report is published by Global Data

Global Data deliver comprehensive, detailed market intelligence that provides a definitive picture of the markets they serve. Their data is complete, detailed, global and completely cross-country comparable.

With different types of data other providers don’t provide, our clients can access a variety of tools that add context to our core data including innovation tracking, sentiment analysis, price monitoring, M&A tracking, competitor intelligence, and city-level intelligence.

Download Free Report Summary PDF

Point-of-Care (POC) Analyzers - Medical Devices Pipeline Assessment, 2019 | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.